When breast cancer spreads to the brain, important molecular changes may occur in the cancer, a small study found.
The discovery of these changes could lead to improved diagnosis and treatment, the researchers said.
About 20 percent of breast cancers are a type known as HER2-positive, which typically respond to targeted therapies. However, HER2-negative breast cancer that has spread to the brain doesn’t respond to the same therapies.
In this study, researchers analyzed tumors from 20 patients in the United States and Ireland. They found that primary breast cancer identified as HER2-negative switched to HER2-positive when it spread to the brain.
The findings show that treatments should target not only the original breast cancer, but also brain tumors, said study author Adrian Lee, director of the Institute for Precision Medicine, part of the University of Pittsburgh Medical Center.
Click here to Read the full article: Breast Cancer Cells May Change When They Spread to Brain: Study
Share this entry
- Jaimie Krzynski, BSN/RN, is Appointed to the American Health Council’s Board of Nurses July 20, 2017
- American Health Council Names Diana Getsy-Holiday, RN, CD, CAP, ChT, BHT, ICADC to Nursing Board July 20, 2017
- The American Health Council Names Paul Aoun, DO/PhD, to Board of Physicians July 19, 2017
- The AHC Names Ferdinando Mirarchi, DO/FAAEM/FACEP, to its Board of Physicians July 18, 2017
- American Health Council Appoints Jonel Kinser, BSN/RN, to its Board of Nurses July 18, 2017
- American Health Council Names Husam Issa, MD, With Admission to Physician Board July 17, 2017